News
2023-12-19
2023, The U.S. Patent and Trademark Office (USPTO) has granted a patent for the diagnostic use of the Cas12 enzyme from Tolo Biotech.
View Details
2023-12-18
2022, Tolo Biotech and Sherlock Biosciences Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
2023-12-17
2020, Tolo Biotech and Sherlock Biosciences sign diagnostic technologies deals
2023-12-16
2020, Tolo and Sherlock create CRISPR agreement
